Transcoronary ablation for septal hypertrophy of hypertrophic obstructive cardiomyopathy

Surgical myectomy has been successfully used to treat patients with symptomatic hypertrophic obstructive cardiomyopathy [HOCM] for the last four decades, but is a major open heart surgery and is available only in selected centers. Transcoronary ablation of septal hypertrophy [TASH] is becoming the preferred approach, because of the novelty of the procedure, being. less traumatic, non surgical technique which is now supported by the evidence of, thousands of successfully treated patients all over the world We present our initial experience which to our knowledge is the first report from this region